Keyphrases
Adverse Events
100%
Chronic Noncancer Pain
100%
Tetrahydrocannabinol
100%
Lack of Response
66%
Clinical Efficacy
33%
Pain Relief
33%
Analgesic
33%
Therapeutic Potential
33%
Patient Selection
33%
Health-related Quality of Life
33%
Pharmacotherapy
33%
Previous Treatment
33%
Orally Administered
33%
Chronic Pain
33%
No Response
33%
Anti-inflammatory Mechanism
33%
Cannabinoids
33%
Δ9-tetrahydrocannabinol (Δ9-THC)
33%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Tetrahydrocannabinol
100%
Analgesic Agent
33%
Pharmacotherapy
33%
Anti-Inflammatory Drug
33%
Chronic Pain
33%
Cannabinoid
33%
Neuroscience
Tetrahydrocannabinol
100%
Anti-Inflammatory
50%
Cannabinoid
50%
Drug Therapy
50%